Phase 2Recruiting

Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study (STOP-NPT3)

Implementing Effective Smoking Cessation Pharmacotherapy for Hospitalized Smokers With Cardiopulmonary Disease

Sponsor
Baystate Medical Center (Academic or other)
Enrolment
424 planned
Conditions
Cardiopulmonary Disease; Smoking Cessation; Inpatient
Interventions
Enhanced Usual Care (EUC); Nurse Practitioner Tobacco Treatment Team (NPT3)
Ages
adults, older adults
Registry
NCT05733767

From the registry

Tobacco use remains the leading cause of death in the United States and contributes to more than 7 million hospitalizations annually. Being admitted to the hospital offers the perfect opportunity to support smoking cessation. Patients are motivated to quit because of their current illness and societal guidelines recommend clinicians should counsel patients and prescribe smoking cessation pharmacotherapy (SCP) to virtually all smokers. However, only 22% of patients are prescribed SCP while hospitalized, and only 1% are prescribed medications compatible with current guidelines. This failure is part of the reason 70-80% of hospitalized smokers eventually relapse. The relapse typically occurs within a few days of hospital discharge - well before outpatient follow-up can occur. The investigators aim to improve smoking cessation treatment and guideline adherence by utilizing the opportunity that hospitalization provides. The investigators have created a tobacco treatment team (T3) to overcome physicians' and patients' low use of current guideline smoking cessation medications. The team…

Primary outcomes

  • Proportion of patients using guideline concordant smoking cessation medication at 7 days
  • Proportion of patients reporting smoking cessation abstinence (7 day point prevalence at 6 months)
Full record on ClinicalTrials.gov